title: Toll-like receptors in the pathogenesis of human B cell malignancies.
abstract: Toll-like receptors (TLRs) are important players in B-cell activation, maturation and memory and may be involved in the pathogenesis of B-cell lymphomas. Accumulating studies show differential expression in this heterogeneous group of cancers. Stimulation with TLR specific ligands, or agonists of their ligands, leads to aberrant responses in the malignant B-cells. According to current data, TLRs can be implicated in malignant transformation, tumor progression and immune evasion processes. Most of the studies focused on multiple myeloma and chronic lymphocytic leukemia, but in the last decade the putative role of TLRs in other types of B-cell lymphomas has gained much interest. The aim of this review is to discuss recent findings on the role of TLRs in normal B cell functioning and their role in the pathogenesis of B-cell malignancies.
authors.forename: Johana M
authors.initials: JM
authors.lastname: Isaza-Correa
authors.forename: Zheng
authors.initials: Z
authors.lastname: Liang
authors.forename: Anke
authors.initials: A
authors.lastname: van den Berg
authors.forename: Arjan
authors.initials: A
authors.lastname: Diepstra
authors.forename: Lydia
authors.initials: L
authors.lastname: Visser
mesh_terms: D001402:B-Lymphocytes / Q000378:metabolism*; D002471:Cell Transformation, Neoplastic / Q000378:metabolism*; D018450:Disease Progression; D006801:Humans; D016393:Lymphoma, B-Cell / Q000503:physiopathology*; D051193:Toll-Like Receptors / Q000378:metabolism*; D019139:Tumor Escape / Q000502:physiology*
chemical_list: D051193:Toll-Like Receptors
references.citation: J Immunol. 2010 Dec 15;185(12):7293-301
references.pmid: 21078901
references.citation: Eur J Immunol. 2006 Apr;36(4):810-6
references.pmid: 16541472
references.citation: Clin Immunol. 2006 Sep;120(3):272-84
references.pmid: 16766226
references.citation: Lancet. 1993 Sep 4;342(8871):575-7
references.pmid: 8102719
references.citation: Cancer Res. 2007 Feb 15;67(4):1823-31
references.pmid: 17308125
references.citation: PLoS One. 2011;6(6):e20651
references.pmid: 21674065
references.citation: Blood. 2005 May 1;105(9):3641-7
references.pmid: 15650062
references.citation: J Hum Genet. 2009 Nov;54(11):655-9
references.pmid: 19745833
references.citation: Eur J Immunol. 2007 Aug;37(8):2205-13
references.pmid: 17621369
references.citation: Blood. 2009 Apr 23;113(17):3969-77
references.pmid: 19144984
references.citation: J Immunol. 2010 May 1;184(9):4615-9
references.pmid: 20368279
references.citation: Cytokine. 2010 Jan;49(1):1-9
references.pmid: 19775907
references.citation: J Immunol. 2005 Apr 1;174(7):4043-50
references.pmid: 15778362
references.citation: Cancer. 2013 Feb 15;119(4):782-91
references.pmid: 22915070
references.citation: Blood. 2007 Mar 1;109(5):2008-13
references.pmid: 17068155
references.citation: Blood. 2006 Apr 15;107(8):3034-44
references.pmid: 16397126
references.citation: J Immunol. 2008 Jul 1;181(1):276-87
references.pmid: 18566393
references.citation: J Immunol. 2004 Oct 1;173(7):4479-91
references.pmid: 15383579
references.citation: J Immunol. 2008 Jan 15;180(2):800-8
references.pmid: 18178818
references.citation: Immunity. 2011 Mar 25;34(3):375-84
references.pmid: 21353603
references.citation: Mol Carcinog. 2011 Jan;50(1):36-46
references.pmid: 21061265
references.citation: Haematologica. 2012 Apr;97(4):595-8
references.pmid: 22102703
references.citation: J Immunol Methods. 2005 May;300(1-2):93-9
references.pmid: 15894327
references.citation: J Clin Immunol. 2011 Feb;31(1):89-98
references.pmid: 20821041
references.citation: Immunology. 2006 Aug;118(4):539-48
references.pmid: 16780564
references.citation: Leukemia. 2006 Feb;20(2):286-95
references.pmid: 16341037
references.citation: Br J Haematol. 2009 Feb;144(4):507-16
references.pmid: 19036098
references.citation: Blood. 2003 Aug 1;102(3):956-63
references.pmid: 12689944
references.citation: Leuk Lymphoma. 2005 Jun;46(6):935-9
references.pmid: 16019542
references.citation: Haematologica. 2008 Feb;93(2):193-200
references.pmid: 18223287
references.citation: Leuk Lymphoma. 2013 Jun;54(6):1268-78
references.pmid: 23078646
references.citation: J Intern Med. 2009 Apr;265(4):421-38
references.pmid: 19298458
references.citation: Leukemia. 2006 Jun;20(6):1130-7
references.pmid: 16628189
references.citation: Eur J Gastroenterol Hepatol. 2001 Nov;13(11):1375-8
references.pmid: 11692066
references.citation: Br J Haematol. 2010 Sep;150(5):543-53
references.pmid: 20629663
references.citation: J Immunol. 2008 Apr 1;180(7):4763-73
references.pmid: 18354200
references.citation: PLoS Pathog. 2011 Oct;7(10):e1002293
references.pmid: 21998589
references.citation: J Immunol. 2011 Jan 15;186(2):878-90
references.pmid: 21149607
references.citation: Genes Immun. 2006 Dec;7(8):615-24
references.pmid: 16971956
references.citation: J Immunol. 2002 May 1;168(9):4531-7
references.pmid: 11970999
references.citation: Leukemia. 2006 Jun;20(6):1138-44
references.pmid: 16617319
references.citation: Oncoimmunology. 2012 Aug 1;1(5):699-716
references.pmid: 22934262
references.citation: Exp Mol Pathol. 2010 Dec;89(3):284-90
references.pmid: 20800061
references.citation: Blood. 2009 Sep 17;114(12):2459-66
references.pmid: 19636062
references.citation: Cell. 1988 Apr 22;53(2):177-84
references.pmid: 2834063
references.citation: Nature. 2011 Feb 3;470(7332):115-9
references.pmid: 21179087
references.citation: N Engl J Med. 2012 Aug 30;367(9):826-33
references.pmid: 22931316
references.citation: Nature. 2011 Feb 24;470(7335):543-7
references.pmid: 21350488
references.citation: J Natl Cancer Inst. 1997 Sep 17;89(18):1350-5
references.pmid: 9308704
references.citation: Br J Haematol. 2009 Aug;146(3):282-91
references.pmid: 19519691
references.citation: Best Pract Res Clin Haematol. 2012 Mar;25(1):101-17
references.pmid: 22409827
references.citation: Nature. 2011 Jun 05;475(7354):101-5
references.pmid: 21642962
references.citation: Cancer Microenviron. 2009 Sep;2 Suppl 1:205-14
references.pmid: 19685283
references.citation: Leukemia. 2007 Jan;21(1):110-20
references.pmid: 17024114
references.citation: Best Pract Res Clin Haematol. 2012 Mar;25(1):75-89
references.pmid: 22409825
references.citation: Blood. 2003 Jun 1;101(11):4500-4
references.pmid: 12560217
references.citation: Carcinogenesis. 2009 Feb;30(2):275-81
references.pmid: 19029192
references.citation: Blood. 2008 Sep 15;112(6):2205-13
references.pmid: 18591383
references.citation: Clin Cancer Res. 2005 Feb 15;11(4):1490-9
references.pmid: 15746051
references.citation: Br J Haematol. 2006 Feb;132(4):452-8
references.pmid: 16412017
references.citation: Nat Rev Immunol. 2004 Jul;4(7):499-511
references.pmid: 15229469
references.citation: Scand J Immunol. 2010 Dec;72(6):540-7
references.pmid: 21044128
references.citation: Blood. 2005 Jan 15;105(2):489-95
references.pmid: 15358617
references.citation: Nature. 2005 Nov 17;438(7066):364-8
references.pmid: 16292312
references.citation: Leukemia. 2010 Jan;24(1):222-6
references.pmid: 19759558
references.citation: Ann Oncol. 2008 Mar;19(3):566-9
references.pmid: 18042837
references.citation: Eur J Immunol. 2004 May;34(5):1483-7
references.pmid: 15114682
references.citation: Blood. 2000 Feb 1;95(3):999-1006
references.pmid: 10648415
references.citation: Annu Rev Immunol. 2012;30:565-610
references.pmid: 22224767